Crystal structures of human transthyretin complexed with glabridin.
Crystal structures of human transthyretin complexed with glabridin.
复制标题
人转甲状腺素蛋白与光甘草定复合物的晶体结构。
DOI:
10.1021/jm401832j
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Mizuguchi M.
中科院分区:
文献类型:
--
作者:
Yokoyama T;Kosaka Y;Mizuguchi M.
Transthyretin (TTR) is a plasma protein implicated in human amyloid diseases. Several small molecules that bind to the thyroxine-binding site of TTR have been shown to stabilize the TTR tetramer and to inhibit amyloid fibril formation of TTR. Herein, we demonstrated that glabridin (Glab), a prenylated isoflavan isolated from Glycyrrhiza glabra L., inhibited aggregation of TTR in a thioflavin assay. The TTR–Glab complex structure revealed a novel binding mode including a CH−π interaction with A108 and a hydrogen bond with K15. A structural comparison with the wild type-apo structure revealed that the CH−π interaction with A108 was strengthened by the induced-fit conformational change upon Glab binding. Furthermore, the binding of Glab induced a rotation of the T119 side chain, and the inclusion of a water molecule, leading to stabilization of the dimer–dimer interface. These results demonstrate that Glab is a novel inhibitor of TTR fibrillization and suggest the molecular mechanism by which Glab binding stabilizes the tetramer.